Table 1.

Population distribution among registered, screened, RADT-positive individuals, and SARS-CoV-2 infection prevalence detected by RADT by age and sex.

Health Area/Variables			Registered	Screened		Positive RADTs
			N	n	%	n	%	95% CI
CBHA			5904	2281	38.6	55	2.41	1.82	3.13
	Age (years)
		0–14	418	108	25.8	1	0.93	0.23	5.05
		15–39	1064	544	51.1	21	3.86	2.41	5.84
		40–64	2424	1120	46.2	26	2.32	1.52	3.38
		≥ 65	1998	509	25.5	7	1.38	0.55	2.81
	Sex
		Men	3052	1157	37.9	32	2.77	1.90	3.88
		Women	2852	1124	39.4	23	2.05	1.30	3.05
SMPBHA			7943	3296	41.5	109	3.31	2.72	3.98
	Age (years)
		0–14	547	164	30.0	3	1.83	0.38	5.25
		15–39	1626	660	40.6	28	4.24	2.84	6.07
		40–64	2894	1310	45.3	47	3.59	2.65	4.74
		≥ 65	2979	1162	39.0	31	2.67	1.82	3.77
	Sex
		Men	4054	1619	39.9	68	4.20	3.28	5.29
		Women	3889	1677	43.1	41	2.44	1.76	3.30
LBHA			144,073	44,915	31.2	276	0.61	0.54	0.69
	Age (years)
		0–14	16,356	3142	19.2	31	0.99	0.67	1.40
		15–39	35,200	10,289	29.2	76	0.74	0.58	0.92
		40–64	56,573	21,573	38.1	124	0.57	0.48	0.68
		≥ 65	35,944	9911	27.6	45	0.45	0.33	0.61
	Sex
		Men	66,603	19,534	29.3	139	0.71	0.60	0.84
		Women	77,470	25,381	32.8	137	0.54	0.45	0.64
Pooled			157,920	50,492	32.0	440	0.87	0.79	0.96
	Age (years)
		0–14	17,321	3414	19.7	35	1.03	0.72	1.42
		15–39	37,890	11,493	30.3	125	1.09	0.91	1.29
		40–64	61,891	24,003	38.8	197	0.82	0.71	0.94
		≥ 65	40,921	11,582	28.3	83	0.72	0.57	0.89
	Sex
		Men	73,709	22,310	30.3	239	1.07	0.94	1.22
		Women	84,211	28,182	33.5	201	0.71	0.62	0.82